---
title: "WUXI BIO held a conference today to announce the latest business updates."
description: "WUXI BIO announced that it will hold a press conference today (4th) to share the latest updates on its business operations, including financial and other information related to the company's operation"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/103652776.md"
published_at: "2023-12-04T01:19:06.000Z"
---

# WUXI BIO held a conference today to announce the latest business updates.

> WUXI BIO announced that it will hold a press conference today (4th) to share the latest updates on its business operations, including financial and other information related to the company's operations. (jl/da)

WUXI BIO (02269.HK) announced that it will hold a conference today (Day 4) to provide the latest updates on its business operations. During the conference, there will be a briefing on the financial and other information related to the company's business operations. (jl/da)

### Related Stocks

- [WXXWY.US - WuXi Biologics](https://longbridge.com/en/quote/WXXWY.US.md)
- [02269.HK - WUXI BIO](https://longbridge.com/en/quote/02269.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| WuXi XDC Launches Cash Offer to Acquire All Remaining Shares of BioDlink | WuXi XDC Cayman Inc. has launched a voluntary conditional cash offer to acquire all remaining shares of BioDlink not alr | [Link](https://longbridge.com/en/news/275670240.md) |
| Wuxi Biologics FY Revenue RMB21,790 Million | WuXi Biologics (Cayman) :FY REVENUE RMB 21,790 MILLIONFY PROFIT EXPECTED TO INCREASE TO RMB5,733 MILLIONFY ADJUSTED NON- | [Link](https://longbridge.com/en/news/275534123.md) |
| Short Interest in Garmin Ltd. (NYSE:GRMN) Increases By 33.2% | Garmin Ltd. (NYSE:GRMN) experienced a 33.2% increase in short interest in January, totaling 3,028,012 shares as of Janua | [Link](https://longbridge.com/en/news/276018254.md) |
| Options trades to play for a short squeeze in Hims & Hers as the pain piles up | Hims & Hers has faced significant challenges, including a lawsuit from Novo Nordisk and a 48% drop in stock value over t | [Link](https://longbridge.com/en/news/275789087.md) |
| The Fatal Flaw in "Back to Starbucks (NASDAQ:SBUX)" | Starbucks' "Back to Starbucks" initiative aims to transform its image from a commodity coffee shop to a cultural hub. Ho | [Link](https://longbridge.com/en/news/276074003.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.